Outcomes Study: Utilization of Risk Stratification in Patients with Diabetes Mellitus in a Health System Specialty Pharmacy Setting

All Posts

Outcomes Study: Utilization of Risk Stratification in Patients with Diabetes Mellitus in a Health System Specialty Pharmacy Setting

Background

Background

  • Diabetes has a high economic burden, accounting for one in four healthcare dollar
  • It is estimated to cost over $16,000 on average to care for a patient with diabetes annually
  • Integration of pharmacists into health systems result in significant hemoglobin A1C (A1C) reductions and improved patient outcomes in patients with diabetes mellitus
  • Limited research has been conducted illustrating how to adopt chronic disease management (CDM) services into a health system specialty pharmacy (HSSP) workflow
  • Risk stratification has been proven successful in other disease states in prioritizing high risk patient

Objectives

The purpose of this study is to assess the effect of patient outcomes after implementing a risk stratification protocol in the HSSP setting for patients with diabetes.

 

Read the Outcomes Study by filling out the form below.

 

 

 

Submit your contact information below to receive insights from our team of pharmacy solutions experts.